Asked by: Lord Brady of Altrincham (Conservative - Life peer)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what discussions his Department has had with Greater Manchester Health and Care Partnership on the release of the NICE technology appraisal on Hybrid closed loop systems for managing blood glucose levels in type 1 diabetes; and if he will make a statement.
Answered by Helen Whately - Shadow Secretary of State for Work and Pensions
NHS Greater Manchester is currently considering the adoption of National Institute for Health and Care Excellence (NICE) guidance in relation to access to glucose monitoring technology. Working with the Greater Manchester Medicines Management Group and provider trusts, NHS Greater Manchester is seeking to review commissioning procedures and bring forward plans for adoption of NICE guidance
NHS Greater Manchester is currently reviewing NICE guidance on making available Technology Appraisals on Hybrid closed loop systems for managing blood glucose levels in type 1 diabetes available.
Asked by: Lord Brady of Altrincham (Conservative - Life peer)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what plans his Department has to improve access to technology to treat type 1 diabetes for local diabetes services in Greater Manchester.
Answered by Helen Whately - Shadow Secretary of State for Work and Pensions
NHS Greater Manchester is currently considering the adoption of National Institute for Health and Care Excellence (NICE) guidance in relation to access to glucose monitoring technology. Working with the Greater Manchester Medicines Management Group and provider trusts, NHS Greater Manchester is seeking to review commissioning procedures and bring forward plans for adoption of NICE guidance
NHS Greater Manchester is currently reviewing NICE guidance on making available Technology Appraisals on Hybrid closed loop systems for managing blood glucose levels in type 1 diabetes available.
Asked by: Lord Brady of Altrincham (Conservative - Life peer)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what discussions his Department has had with (a) the Greater Manchester Health and Care Partnership, (b) Lancashire and South Cumbria Integrated Care System and (c) Cheshire and Merseyside Health and Care Partnership on plans to collaboratively support people with type one diabetes to access timely and localised care.
Answered by Helen Whately - Shadow Secretary of State for Work and Pensions
The Department has held no discussions with the Greater Manchester Health and Care Partnership, Lancashire and South Cumbria Integrated Care System or Cheshire and Merseyside Health and Care Partnership on plans to collaboratively support people with type one diabetes to access timely and localised care
The NHS Long Term plan sets out how NHS will enhance its support offer for those people living with type one diabetes, including further expanding the provision of structured education and digital self-management support tools.
The Major Conditions Strategy will set out how we intend to tackle conditions that contribute most to morbidity and mortality across the population in England which includes diabetes.
Asked by: Lord Brady of Altrincham (Conservative - Life peer)
Question to the HM Treasury:
To ask the Chancellor of the Exchequer, if he will make an assessment of the potential merits of introducing a price stability mechanism, such as a contracts-for-difference scheme similar to that used in wind power generation, to encourage the production of sustainable aviation fuel production in the UK.
Answered by James Cartlidge - Shadow Secretary of State for Defence
The government is committed to supporting the uptake of Sustainable Aviation Fuels (SAF). The UK’s SAF programme is one of the most comprehensive in the world, that includes the £180 million Advanced Fuels Fund and an ambitious SAF mandate which other low carbon technologies do not have.
On 17 April, we published a government response to an independent report on a UK SAF industry. It sets out how we are already taking action to address many of the report’s recommendations. We have committed to continue working with industry to consider the case for broader support alongside the AFF and the SAF mandate from 2025 (that will provide a long-term investment signal and price support), with a focus on industry funded intervention, to increase revenue certainty for UK SAF plants. If required following that work, we will launch a formal consultation this summer.
Asked by: Lord Brady of Altrincham (Conservative - Life peer)
Question to the HM Treasury:
To ask the Chancellor of the Exchequer, if his Department will make an assessment of the potential value of the sustainable aviation fuel sector to the UK economy.
Answered by James Cartlidge - Shadow Secretary of State for Defence
The government is committed to supporting the uptake of Sustainable Aviation Fuels (SAF). The UK’s SAF programme is one of the most comprehensive in the world, that includes the £180 million Advanced Fuels Fund and an ambitious SAF mandate which other low carbon technologies do not have.
On 17 April, we published a government response to an independent report on a UK SAF industry. It sets out how we are already taking action to address many of the report’s recommendations. We have committed to continue working with industry to consider the case for broader support alongside the AFF and the SAF mandate from 2025 (that will provide a long-term investment signal and price support), with a focus on industry funded intervention, to increase revenue certainty for UK SAF plants. If required following that work, we will launch a formal consultation this summer.
Asked by: Lord Brady of Altrincham (Conservative - Life peer)
Question to the HM Treasury:
To ask the Chancellor of the Exchequer, whether his Department made an assessment of the average proportion contributed to the income of hospitality venues by (a) wines and (b) spirits when formulating plans for the draught relief introduced on 1 August 2022.
Answered by James Cartlidge - Shadow Secretary of State for Defence
The Government consulted extensively and took account of evidence from a wide range of stakeholders and a variety of data sets as part of the tax policy making process on the alcohol review, including on the design of Draught Relief.
The Government has committed to evaluating the policy and its impacts after implementation.
Asked by: Lord Brady of Altrincham (Conservative - Life peer)
Question to the HM Treasury:
To ask the Chancellor of the Exchequer, if he will make an assessment of the potential merits of introducing measures to assist (a) producers and (b) importers supplying the off trade in alcoholic drinks following the increases in alcohol duty announced in the Spring Budget 2023.
Answered by James Cartlidge - Shadow Secretary of State for Defence
The new alcohol duty system will provide a simpler and more consistent duty regime for producers and importers supplying the off trade and on trade.
The Government is also introducing specific measures that will benefit produces and importers. The approval, return and payment processes for domestic producers of alcoholic products are being harmonised. Small Producer Relief reforms and extends the relief currently enjoyed by small breweries to all producers of other alcoholic products under 8.5% abv. Temporary arrangements for producers and importers of wine in place until 1 February 2025 will help them manage the transition to the new method of calculating the duty on their products.
The Government has also committed to evaluating the policy and its impacts after implementation.
Asked by: Lord Brady of Altrincham (Conservative - Life peer)
Question to the HM Treasury:
To ask the Chancellor of the Exchequer, whether his Department has made a recent assessment of the potential impact of planned wine duty increases on (a) elasticity of demand and (b) forecast levels of future revenue to the Exchequer from alcohol duty.
Answered by James Cartlidge - Shadow Secretary of State for Defence
The Office for Budget Responsibility (OBR) published its latest Economic and Fiscal Outlook report in March 2023. The publication contained an alcohol duty revenue forecast up to and including 2027-28 and was inclusive of all planned changes to alcohol duties including wine duty increases.
Table 2.12 in the supplementary tables published alongside the Economic and Fiscal Outlook report contains separate clearance and receipt forecasts by type of alcohol.
Asked by: Lord Brady of Altrincham (Conservative - Life peer)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, with reference to The Khan review: making smoking obsolete, published on 9 June 2022, whether his Department's response to that review will set out measures to (a) strengthen enforcement of vaping regulation and (b) stop the import and sale of vaping products that do not comply with the Tobacco and Related Products Regulations 2016.
Answered by Neil O'Brien - Shadow Minister (Policy Renewal and Development)
In order to support proposals set out in the Khan review, it is essential that consumers have access to high quality products while reducing the supply of non-compliant and smuggled goods entering through illegal channels. The Medicines and Healthcare products Regulatory Agency (MHRA) is currently working closely with a number of regulatory and enforcement agencies, providing product and manufacturer information to assist in both strategic planning and direct enforcement of the Tobacco and Related Products Regulations 2016. In addition to this, the MHRA is supporting the work of regulatory stakeholders across a range of related vaping and general legislation for the purposes of compliance and law enforcement.
Asked by: Lord Brady of Altrincham (Conservative - Life peer)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the overall effectiveness of the MHRA in supporting and evaluating clinical trials in the UK; and what assessment he has made of the potential future risks to that effectiveness.
Answered by Will Quince
The Medicines and Healthcare products Regulatory Agency (MHRA) recently underwent a programme organisational reform and transformation, supported by independent advisors, to deliver an agency able to modernise medicines and medical device regulation in the United Kingdom and take advantage of its new sovereign regulator status. This process and the ongoing implementation of the changes is under constant review by MHRA itself and departmental officials, including any impact on delivery and effectiveness. As part of that and the normal business planning cycles, the two teams will continue to work together to support the Agency to continue to protect the health of the UK population including ensuring the safety of clinical trials.